Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling

被引:443
作者
Withers, DJ [1 ]
Burks, DJ [1 ]
Towery, HH [1 ]
Altamuro, SL [1 ]
Flint, CL [1 ]
White, ME [1 ]
机构
[1] Harvard Univ, Sch Med, Howard Hughes Med Inst, Joslin Diabet Ctr, Boston, MA 02215 USA
关键词
D O I
10.1038/12631
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Insulin receptor substrates (Irs proteins) mediate the pleiotropic effects of insulin and Igf-l (insulin-like growth factor-1), including regulation of glucose homeostasis and cell growth and survival. We intercrossed mice heterozygous for two null alleles (Irs1(+/-) and Irs2(+/-)) and investigated growth and glucose metabolism in mice with viable genotypes. Our experiments revealed that Irs-1 and Irs-2 are critical for embryonic and post-natal growth, with Irs-l having the predominant role. By contrast, both Irs-l and Irs-2 function in peripheral carbohydrate metabolism, but Irs-2 has the major role in beta-cell development and compensation for peripheral insulin resistance. To establish a role for the Igf-l receptor in beta-cells, we intercrossed mice heterozygous for null alleles of Igf1r and Irs2. Our results reveal that Igf-l receptors promote beta-cell development and survival through the Irs-2 signalling pathway. Thus, Irs-2 integrates the effects of insulin in peripheral target tissues with Igf-l in pancreatic beta-cells to maintain glucose homeostasis.
引用
收藏
页码:32 / 40
页数:9
相关论文
共 36 条
[11]   Transcribing pancreas [J].
Edlund, H .
DIABETES, 1998, 47 (12) :1817-1823
[12]  
GUZ Y, 1995, DEVELOPMENT, V121, P11
[13]  
HERRERA PL, 1991, DEVELOPMENT, V113, P1257
[14]   Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent -: Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 CELLS [J].
Hügl, SR ;
White, MF ;
Rhodes, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (28) :17771-17779
[15]   Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes [J].
Kulkarni, RN ;
Brüning, JC ;
Winnay, JN ;
Postic, C ;
Magnuson, MA ;
Kahn, CR .
CELL, 1999, 96 (03) :329-339
[16]   MOLECULAR AND CELLULAR ASPECTS OF THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR [J].
LEROITH, D ;
WERNER, H ;
BEITNERJOHNSON, D ;
ROBERTS, CT .
ENDOCRINE REVIEWS, 1995, 16 (02) :143-163
[17]   The insulin-like growth factor-I receptor and apoptosis - Implications for the aging progress [J].
LeRoith, D ;
Parrizas, M ;
Blakesley, VA .
ENDOCRINE, 1997, 7 (01) :103-105
[18]  
LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K
[19]   IRS-1 IS A COMMON ELEMENT IN INSULIN AND INSULIN-LIKE GROWTH FACTOR-I SIGNALING TO THE PHOSPHATIDYLINOSITOL 3'-KINASE [J].
MYERS, MG ;
SUN, XJ ;
CHEATHAM, B ;
JACHNA, BR ;
GLASHEEN, EM ;
BACKER, JM ;
WHITE, MF .
ENDOCRINOLOGY, 1993, 132 (04) :1421-1430
[20]   Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes [J].
Rother, KI ;
Imai, Y ;
Caruso, M ;
Beguinot, F ;
Formisano, P ;
Accili, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (28) :17491-17497